American Society of Clinical Oncology (ASCO)’s Post

Registration is open for the free webinar 'Accurate variant classification and clinical impact of variability' as part of our BRCA and HRR gene variant classification assessments that we are running jointly with GenQA in 2024. This webinar will include: ·        CanVIG-UK recommendations for classification of reduced penetrance variants in high-penetrance cancer susceptibility genes (Dr Alice Garrett, Institute of Cancer research, UK) ·        Interpretation of Splice variants in HRR genes (Miranda Durkie, Sheffield Diagnostic Genetics Service, UK) ·        Review of learning from Run 12 (Prof Kathleen Claes, Ghent University Hospital, Belgium). Register for this webinar at https://lnkd.in/edpkM_ZD #BRCA #HRR #variantclassification #quality

Interested in learning more about the latest advances in the area of risk mitigation design & effectiveness. Make sure to join me and register to the pre-conference course at the upcoming #ISoP2024Montreal that includes an international panel of experts. #PV #Patientsafety #RMP #pharmacovigilance

1 day left to apply for the small number of bursaries still available for the upcoming 3rd RSC / SCI New Therapeutics for Global Health meeting❗ (previously known as Medicinal Chemistry for Global Health). If you wish to attend this meeting but you or your organisation may have difficulty with funding, you may still be able to take part by applying for a bursary to contribute to costs before Friday 9th August! To find out more and apply, visit the event website here https://lnkd.in/erQB69fR #NTGH24 #GHMC #MCGH #NewTherapeutics #MedicinalChemistry

Are you or someone you know thinking about enrolling in a clinical trial and unsure about joining? Here is what you need to know: https://lnkd.in/emfgt5Dn Great read from Conquer: the journey informed and AONN+

Today I’m so proud to share the full version of Alexion Pharmaceuticals, Inc.’s first short film, Rare Connections in NMOSD, which centers the voices of our patients and their families. I hope you will join me in making an impact in the months to come by sharing this film and these stories, to foster connections and spark important conversations. In Rare Connections we hear from Marie, Alex, and Craig, who share the strength, resilience, and beauty of their community, along with the significant challenges they experience living with NMOSD. While every rare disease patient has their own unique story, many of them share a similar, and often difficult, journey. From a lengthy quest to get a proper diagnosis to difficulty accessing quality care, these are the all-too-common stories that underscore the need for policy changes and better care access opportunities for patients. We can only achieve this through close collaboration with the entire rare disease community. This is why at Alexion Pharmaceuticals, Inc. we are focused on improving equity and health outcomes for people living with rare diseases by working to reduce the time to diagnosis, improve access to care, and engaging with global policymakers to amplify impact. Many thanks to Elizabeth Preston, Julie Block, the Alexion Patient Experience team and everyone across our organization who worked so hard to make this film a reality. https://lnkd.in/d5KRd9ip  

The ImageBloom team is excited to announce our latest partnership with GLSA | Global Life Sciences Alliance. Find out how our collaboration aims to foster innovation and efficiency in the life sciences industry. #partnership #lifesciences #clinicaltrials #research #patientrecruitment #collaboration #imagebloom #glsa

This month to celebrate the "Love Drug", we're running a 30% off sale our on our in-depth online course "Foundations in MDMA Safety, Therapeutic Applications & Research". If exploring MDMA is of interest to you, now is the time to jump into the course! If you'd like to explore some topics we cover first, here are the top 10 articles on our site about MDMA: https://lnkd.in/gsvFHZ-q

As part of PSA's work with the QUM Alliance, members and pharmacists are invited to join next week's multidisciplinary webinar exploring the impact of Eczema and what we can do to best support our patients. With more education opportunities tailored for pharmacists available soon, this webinar is a great introduction to eczema, its causes and triggers, and common factors in treatment failure. Register to attend by visiting https://buff.ly/3SMJYd5

In a companion piece Jake asks: what are the simple things we can do RIGHT NOW to improve the clinical trial processs, and why aren’t we? No day like today. https://lnkd.in/e_ND6hf4

Of Course